Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vorinostat Continuation in Advanced Cancers
NCT00907738Phase 2Completed
- Sponsor
- Merck & Co.
- Start
- Aug 2005
- Primary completion
- Jun 2010
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules
01
Overview
A Phase 2 trial of vorinostat in cancer, sponsored by Merck & Co.. Started Aug 2005; status: completed.
02
Drugs
vorinostat
03
Conditions
cancer
Beyond the preview
Go deeper on NCT00907738.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00907738.